Millions of people in the U.S. are affected by diabetic retinopathy, a complication of diabetes that affects the eyes. The condition is caused by damage to the blood vessels in the retina, the light-sensitive tissue at the back of the eye. At first, diabetic retinopathy might not cause any symptoms, or the problems might be mild. However, if the underlying diabetes remains poorly managed, it can lead to blindness.
In a new study, University of Michigan researchers showed that treatment with the molecule norrin can prevent vision loss in diabetic rats. The study is published in the journal Diabetes.
Diabetic retinopathy treatment
Current therapies for diabetic retinopathy target vascular endothelial growth factor, or VEGF, a protein that causes new blood vessels to form.
VEGF a...
Read More
Recent Comments